Your browser doesn't support javascript.
loading
Unleashing NK- and CD8 T cells by combining monalizumab and trastuzumab for metastatic HER2-positive breast cancer: Results of the MIMOSA trial.
Geurts, V C M; Voorwerk, L; Balduzzi, S; Salgado, R; Van de Vijver, K; van Dongen, M G J; Kemper, I; Mandjes, I A M; Heuver, M; Sparreboom, W; Haanen, J B A G; Sonke, G S; Horlings, H M; Kok, M.
Afiliação
  • Geurts VCM; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Voorwerk L; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Balduzzi S; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Salgado R; Department of Pathology, ZAS, Antwerp, Belgium; Division of Research, Peter Mac Callum Cancer Center, Melbourne, Victoria, Australia.
  • Van de Vijver K; Department of Pathology, University Hospital Ghent, Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • van Dongen MGJ; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Kemper I; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Mandjes IAM; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Heuver M; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Sparreboom W; Astra Zeneca, The Hague, the Netherlands.
  • Haanen JBAG; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Horlings HM; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Kok M; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: M.Kok@nki.nl.
Breast ; 70: 76-81, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37393645

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mimosa Limite: Female / Humans Idioma: En Revista: Breast Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mimosa Limite: Female / Humans Idioma: En Revista: Breast Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda